Agreement 750 Views Oasmia signs manufacturing agreement with Lonza Malin Otmani March 21, 2022 The companies have signed a …
Biotech Business 838 Views Oasmia changes name and resolves a new issue of shares Malin Otmani January 19, 2022 The Board of Directors of …
Clinical Trials 889 Views First patient enrolled in Oasmia trial Malin Otmani June 11, 2021 Oasmia Pharmaceutical has announced that …
Collaboration 642 Views Oasmia enters collaboration with Karolinska Institutet Malin Otmani March 5, 2021 The collaboration will generate new …
Acquisition 986 Views Oasmia acquires rights for Cantrixil Malin Otmani March 1, 2021 Oasmia Pharmaceutical has signed an …
Agreement 1261 Views Oasmia’s partner Elevar Therapeutics signs agreement with Taiba Malin Otmani October 6, 2020 Oasmia Pharmaceutical announces that Elevar …
In a new job 1655 Views Oasmia Pharmaceutical appoints new Chief Financial Officer Malin Otmani September 9, 2020 Oasmia Pharmaceutical has announced the …
New Market 2161 Views Oasmia launches its ovarian cancer treatment drug in Sweden, Denmark and Finland Malin Otmani February 4, 2020 Oasmia Pharmaceutical is launching its …
New Market 1430 Views Oasmia receives market approval in Russia Malin Otmani August 15, 2017 Oasmia Pharmaceutical has received marketing …
